This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: side effects

December 2024 Br J Cardiol 2024;31:126–7 doi:10.5837/bjc.2024.051

SGLT2 inhibitors: cardiac superheroes with caveats

Ismail Sooltan, Hesham Ismail, Aqib Khan, Sudantha Bulugahapitiya

Abstract

SGLT2 inhibitors exert their cardioprotective effect through several proposed mechanisms. Primarily, by inhibiting the SGLT2 in the proximal renal tubules, these agents promote urinary glucose excretion, leading to reductions in serum glucose levels, body weight, and blood pressure.1,2 Additionally, SGLT2 inhibitors are thought to drive cardiovascular benefits by promoting natriuresis and diuresis, reducing preload and afterload on the heart.1,2 They also appear to improve myocardial energetics, reduce oxidative stress and inflammation, and exert favourable effects on cardiac remodelling and vascular function.1,2 The DAPA-HF (Dapagliflozin a

| Full text

March 2003 Br J Cardiol 2003;10:137-40

Sibutramine: a safety profile

Omar Ali

Abstract

No content available

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now